欧洲29国抗菌药物耐药与消耗关系存在国家间差异
该观察性研究分析欧洲经济区29国2013年社区抗菌药物消耗率与2014年医院耐药率的关系,耐药数据基于196480株侵袭性分离株。结果显示二者在19种细菌中呈强至中度相关(r=0.84至r=0.39),但关联并不一致,部分国家偏离趋势。
要点
- 国家社区抗菌药物消耗与医院耐药率总体相关,但关联强度因菌种和国家而异。
- 法国、比利时、卢森堡表现为高消耗低耐药,保加利亚、匈牙利、拉脱维亚表现为低消耗高耐药。
- 医院侵袭性感染的耐药可能由不同机制驱动,需考虑环境、农业用药、疫苗政策与处方质量。
核心结论
- 欧洲29国社区抗菌药物消耗率与医院耐药率在多种细菌中存在关联,但关联并不一致,部分国家偏离总体趋势。
研究设计与样本
- 观察性研究,覆盖欧洲经济区29个国家;消耗率来自ESAC-Net(2013年),耐药率来自EARS-Net(2014年,基于196480株侵袭性分离株)。
主要发现
- 国家抗菌药物消耗率从≤13 DDD(爱沙尼亚、荷兰、瑞典)到≥30 DDD(法国、希腊、罗马尼亚)每1000居民每日不等。
- 国家耐药率(医院分离株,15种)从<6.1%(芬兰、冰岛、瑞典)到>37.2%(保加利亚、希腊、罗马尼亚、斯洛伐克)不等。
- 消耗率与医院耐药率在19种细菌中呈强至中度相关(r=0.84至r=0.39)。
临床怎么用
- 提示抗菌药物管理应结合本国耐药与消耗的实际关联特征,不能简单以消耗量推断耐药水平。
- 对高消耗低耐药或低消耗高耐药国家,应进一步排查环境、农业用药、疫苗政策与处方质量等因素。
局限性
- 部分国家未报告每种耐药菌株的数据,数据可得性与一致性虽好但存在缺口。
- 研究为观察性设计,关联不等于因果,未纳入环境、农业使用、疫苗政策与处方质量等因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance in invasive infections is driven mainly by human antimicrobial consumption. Limited cross-national comparative evidence exists about variation in antimicrobial consumption and effect on resistance. METHODS: We examined the relationship between national community antimicrobial consumption rates (2013) and national hospital antimicrobial resistance rates (2014) across 29 countries in the European Economic Area (EEA). Consumption rates were obtained from the European Surveillance of Antimicrobial Consumption Network (ESAC-Net). Resistance data were obtained from the European Antimicrobial Resistance Surveillance Network (EARS-Net), based on 196480 invasive isolates in 2014. RESULTS: Data availability and consistency were good. Some countries did not report figures for each strain of resistant bacteria. National antimicrobial consumption rates (2013) varied from ≤ 13 DDD (Estonia, the Netherlands and Sweden) to ≥ 30 DDD (France, Greece and Romania) per 1000 inhabitants per day. National antimicrobial resistance rates (hospital isolates, 15 species) also varied from <6.1% (Finland, Iceland and Sweden) to > 37.2% (Bulgaria, Greece, Romania and Slovakia). National antimicrobial consumption rates (2013) showed strong to moderate correlation with national hospital antimicrobial resistance rates (2014) in 19 strains of bacteria (r = 0.84 to r = 0.39). Some countries defied the trend with high consumption and low resistance (France, Belgium and Luxembourg) or low consumption and high resistance (Bulgaria, Hungary and Latvia). CONCLUSIONS: We found associations between national community antimicrobial consumption and national hospital antimicrobial resistance across a wide range of bacteria. These associations were not uniform. Different mechanisms may drive resistance in hospital-based invasive infections. Future research on international variations in antimicrobial resistance should consider environmental factors, agricultural use, vaccination policies and prescribing quality.
引用
- McDonnell L, Armstrong D, Ashworth M, et al. National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries. J Antimicrob Chemother. 2017. PMID: 28961862. doi:10.1093/jac/dkx248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。